One of the hottest pharmacological trends in medicine, GLP-1 receptor agonists like Ozempic, comes with a key red flag for ...

Prescription drugs account for 15% of health care costs. Yet, they’re our best defense against the chronic diseases that ...

Nationwide shutdown called as tensions rise over police allegations Should Audi, Mercedes, and BMW Be Worried? Nio ET9 Luxury ...

GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...

Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

Aureus Asset Management, an $8 billion registered investment advisor in Boston, has been recommending alternative investments ...

Progressive Grocer talks with analysts about fresh research affirming the impact of GLP-1 medications on grocery product ...

In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 receptor agonist. High-profile endorsements, including from Elon Musk, have ...

GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.

Drug development is a decade-long and costly process replete with failures. If we don’t incentivize continued investments in ...